Chemomab Therapeutics
CMMB
6 hedge funds and large institutions have $763K invested in Chemomab Therapeutics in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
20% more funds holding
Funds holding: 5 → 6 (+1)
0.01% less ownership
Funds ownership: 0.04% → 0.03% (-0.01%)
41% less capital invested
Capital invested by funds: $1.29M → $763K (-$528K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$13.9K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$2.51K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$217K |
| 2 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$138K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PCM
1
Palisade Capital Management
Fort Lee,
New Jersey
| $421K | – | – | – |
|
|
MIH
2
Meitav Investment House
Bene-Beraq,
Israel
| $267K | -$138K | -2,035 | -36% |
|
|
RC
3
RegentAtlantic Capital
Morristown,
New Jersey
| $29K | – | – | – |
|
|
PF
4
Phoenix Financial
Givatayim,
Israel
| $28K | – | – | – |
|
|
VF
5
Virtu Financial
New York
| $15K | +$13.9K | +205 | New |
|
|
6
Osaic Holdings
Scottsdale,
Arizona
| $3K | +$2.51K | +37 | New |
|
|
AIC
7
AWM Investment Company
New York
| – | -$217K | -2,471 | Closed |
|
CMMB Hedge Fund Activity: Q3 2020 in Review
6 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Chemomab Therapeutics (CMMB) for Q3 2020, worth a combined $763K — down 41% from $1.29M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CMMB positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $13.9K. The largest seller was AWM Investment Company, exiting entirely with an estimated $217K sold.
- 6 institutional investors held Chemomab Therapeutics (CMMB) as of Q3 2020, up from 5 in Q2 2020.
- Funds reported $763K of Chemomab Therapeutics stock for Q3 2020, down 41% quarter-over-quarter.
- 2 funds opened new Chemomab Therapeutics positions in Q3 2020 and 1 closed out, a net change of +1 holder.
- The largest Chemomab Therapeutics buyer in Q3 2020 was Virtu Financial, an estimated $13.9K added.
- The largest Chemomab Therapeutics seller in Q3 2020 was AWM Investment Company, an estimated $217K sold.
Based on aggregated 13F filings for Q3 2020.